2,373.05
-104.45
(-4.22%)
At close: January 10 at 3:30:02 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
3,747,800.00
3,183,900.00
2,713,700.00
3,367,300.00
2,686,100.00
Investing Cash Flow
-2,967,800.00
-3,200,400.00
-2,175,800.00
-3,767,700.00
-294,400.00
Financing Cash Flow
-398,000.00
-380,700.00
-281,700.00
-406,800.00
-239,800.00
End Cash Position
1,761,000.00
1,387,000.00
1,775,600.00
1,507,600.00
4,311,100.00
Capital Expenditure
-1,437,900.00
-1,458,200.00
-1,934,700.00
-911,800.00
-733,300.00
Issuance of Capital Stock
100.00
100.00
200.00
300.00
--
Free Cash Flow
2,309,900.00
1,725,700.00
779,000.00
2,455,500.00
1,952,800.00
3/31/2021 - 6/23/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AJANTPHARM.NS Ajanta Pharma Limited
2,834.20
-3.44%
INNOVACAP.NS Innova Captab Limited
1,081.55
-3.46%
APLLTD.NS Alembic Pharmaceuticals Limited
1,010.05
-4.24%
SEQUENT.NS Sequent Scientific Limited
177.68
-4.69%
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,541.70
-3.24%
NATCOPHARM.NS NATCO Pharma Limited
1,235.55
-4.09%
SUVENPHAR.NS Suven Pharmaceuticals Limited
1,061.95
-3.81%
BAJAJHCARE.NS Bajaj HealthCare Limited
536.65
-1.64%
ZYDUSLIFE.NS Zydus Lifesciences Limited
1,004.40
-0.60%
BLISSGVS.NS Bliss GVS Pharma Limited
160.47
-3.88%